Protalix BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Protalix BioTherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $0.03 | $0.06 | -50.0 % |
Jun 2024 | 2024-08-14 | $-0.03 | $0.02 | -250.0 % |
Mar 2024 | 2024-05-10 | $-0.06 | $-0.02 | -200.0 % |
Dec 2023 | 2024-03-14 | $-0.07 | $-0.03 | -133.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $17.96M | $16.26M | 10.4 % |
Jun 2024 | 2024-08-14 | $13.47M | $12.50M | 7.79 % |
Mar 2024 | 2024-05-10 | $3.75M | $9.20M | -59.3 % |
Dec 2023 | 2024-03-14 | $10.49M | $5.80M | 80.8 % |
Protalix BioTherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Protalix BioTherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $0.03, which missed the estimate of $0.06.
Protalix BioTherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.